Yu YM, Chen Q, Guo, et al
Gaucher Disease News: Cerezyme Becomes First FDA-Approved Therapy for Type 3 Gaucher Disease New Treatment for Progressive Pulmonary Fibrosis Lung Disease The FDA approved Boehringer Ingelheims Jascayd (nerandomilast) tablets to treat adults with progressive pulmonary fibrosis (PPF)
In July 2024, Roche, a Swiss-based pharmaceuticals company, acquired Carmot Therapeutics for US$ 2.7 billion (with up to US$ 400 million in additional milestone payments)
Mutltifaceted biological roles of leptin
At Vermont Med Spa, were committed to helping you achieve your health goals with integrity, transparency, and personalized care
Pascal La grandeur de lhomme est grande en ce quil se sait misrable